Neuropix develops neurostimulation devices that deliver targeted electrical impulses to modulate neural activity, providing a non-invasive alternative for chronic pain management. This technology enhances neurological function and improves patient quality of life without reliance on pharmaceuticals.
Funding
$2.2M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many neurological disorders, such as epilepsy, migraines, and neurodegenerative diseases, are primarily managed with medications that are not always effective and can have significant side effects. Existing neurostimulation devices often require invasive surgical procedures, are bulky, and can be burdensome for patients.
Solution
Neuropix offers a non-invasive, wearable neurostimulation device that delivers targeted electrical pulses to modulate neural activity and rebalance brain chemistry. The wireless in-ear device provides transcutaneous vagus nerve stimulation (tVNS) by activating nerve fibers in the ear, which in turn stimulate the vagus nerve, a key component of the nervous system. This tVNS treatment helps reset the balance of neurotransmission in the brain, alleviating symptoms of various neurological disorders and offering a drug-free alternative or supplement to medication.
Target Audience
The primary target audience includes individuals suffering from neurological disorders such as epilepsy, migraines, anxiety, stress, and sleep disorders, as well as those seeking non-pharmacological treatments or adjunctive therapies to manage their conditions.
Features
- Wireless and portable in-ear design for convenient, self-administered therapy
- Non-invasive transcutaneous vagus nerve stimulation (afVNS)
- Targeted electrical pulses to stimulate key nerve fibers and modulate brain signals
- Clinically developed to rebalance brain chemistry and ease disease symptoms
- Potential treatment option for neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease
- CE marked
- Scientifically validated